Amgen, Inc.

( )
AMGN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. 1.08%63.831.0%$551.10m
AMGNAmgen, Inc. -1.17%222.951.3%$476.07m
BIIBBiogen, Inc. 1.08%281.141.4%$399.23m
ILMNIllumina, Inc. -1.77%313.923.5%$326.48m
VRTXVertex Pharmaceuticals, Inc. -0.74%227.371.9%$275.87m
REGNRegeneron Pharmaceuticals, Inc. -1.70%339.422.6%$247.62m
EXASEXACT Sciences Corp. -1.83%87.9324.0%$226.92m
ALXNAlexion Pharmaceuticals, Inc. 0.03%105.302.0%$177.32m
AAgilent Technologies, Inc. -1.92%86.571.6%$135.93m
INCYIncyte Corp. -0.87%76.072.5%$127.85m
BMRNBioMarin Pharmaceutical, Inc. -1.78%84.624.3%$112.31m
SRPTSarepta Therapeutics, Inc. -0.69%111.6214.6%$108.69m
SGENSeattle Genetics, Inc. -2.77%110.436.1%$106.10m
DERMDermira, Inc. 0.00%18.713.8%$87.37m
BLUEbluebird bio, Inc. -4.74%83.1214.2%$84.78m

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.